List of Studies ( Metabolite:Ondansetron)
Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Units(range) |
---|---|---|---|---|---|---|---|
ST002016 | AN003284 | Metabolomics of COVID patients | Blood | Human | COVID-19 | University of Virginia | intensity |
ST000148 | AN000235 | A549 13C-labeled Cell Study | Epithelial cells | Human | Cancer | University of Kentucky | normalized corrected peak area |
ST001844 | AN002987 | Identification of unique metabolite networks between Latino and Caucasian patients with nonalcoholic fatty liver disease (NAFLD) (part III) | Blood | Human | Fatty liver disease | University of California, Davis | normalized peak height |
ST001844 | AN002987 | Identification of unique metabolite networks between Latino and Caucasian patients with nonalcoholic fatty liver disease (NAFLD) (part III) | Liver | Human | Fatty liver disease | University of California, Davis | normalized peak height |
ST002003 | AN003266 | A case-control study on plasma metabolomics analysis in Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) (Part 4) | Blood | Human | Myalgic encephalomyelitis/chronic fatigue syndrome | Columbia University | normalized peak height |
ST000142 | AN000225 | H1299 13C-labeled Cell Study | Lung | Human | Cancer | University of Kentucky | Peak area |
ST000221 | AN000329 | Normal plasma cells,Low proliferation multiple myeloma and High proliferation multiple myeloma cells | Bone marrow | Human | Cancer | Mayo Clinic | Peak area |
ST002094 | AN003420 | Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) | Feces | Human | Irritable bowel syndrome | Mayo Clinic | raw intensity |
ST002094 | AN003421 | Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) | Feces | Human | Irritable bowel syndrome | Mayo Clinic | raw intensity |
ST002089 | AN003411 | Plasma metabolomic signatures of COPD: A metabolomic severity score for airflow obstruction and emphysema. | Blood | Human | COPD | National Jewish Health | relativeMedian |